Skip to content
TRUTH IN PEPTIDES

Sexual Health (Men)

Evidence-based approaches to male sexual function

Compounds studied for erectile function, libido, and overall male sexual health. This area has some of the strongest pharmaceutical evidence in the peptide-adjacent space.

Protocol Map

Compounds organized by evidence tier. Foundation compounds have the strongest clinical support. Emerging compounds show promise but lack robust human data.

Foundation

Sildenafil or TadalafilPeer Reviewed

PDE5 inhibitors for erectile function

PDE5 inhibitors are the first-line treatment for erectile dysfunction with decades of RCT data. Sildenafil (on-demand, 4-6 hour duration) and Tadalafil (daily low-dose or on-demand, up to 36 hours) have different pharmacokinetic profiles suited to different patient needs.

Commonly Added

TestosteronePeer Reviewed

Address underlying hormonal deficiency

Low testosterone is a common contributor to decreased libido and erectile function. TRT in men with confirmed hypogonadism has been shown to improve desire, arousal, and erectile function in multiple RCTs. Should be confirmed with morning labs.

PT-141 (Bremelanotide)Clinical Data

Central-acting sexual function agent

A melanocortin receptor agonist that acts on the central nervous system rather than the vascular system. FDA-approved for female HSDD; used off-label in men when PDE5 inhibitors are insufficient. Works on desire/arousal pathways.

Emerging

OxytocinEmerging Research

Bonding and arousal support

Sometimes called the "bonding hormone." Small studies suggest nasal oxytocin may enhance sexual satisfaction and partner bonding. Evidence is preliminary, and the clinical significance of effects remains debated.

Recommended Monitoring

Lab work and clinical assessments commonly recommended when pursuing this goal. Your provider will determine the appropriate testing schedule for your situation.

Monitoring recommendations based on published clinical guidelines and expert consensus
TestFrequencyPurpose
Total and Free TestosteroneBaseline (morning draw), then every 6 months if on TRTConfirm hypogonadism and monitor replacement therapy
Estradiol (sensitive)Baseline, then every 6 months if on TRTEstrogen balance affects libido and erectile function
Cardiovascular AssessmentBaseline, especially before starting PDE5 inhibitorsED can be an early marker of cardiovascular disease; screening is essential
ProlactinBaselineElevated prolactin is a treatable cause of sexual dysfunction
Thyroid PanelBaselineBoth hypo- and hyperthyroidism can impair sexual function
Lipid PanelBaseline, then annuallyCardiovascular risk assessment; vascular health directly impacts erectile function

Lifestyle Foundations

Cardiovascular exercise is directly correlated with erectile function -- even moderate walking 30 minutes daily shows measurable improvement in clinical studies. Maintaining a healthy weight reduces estrogen conversion and improves vascular health. Sleep quality impacts testosterone production, which peaks during deep sleep. Stress management and mental health support are critical, as psychological factors are the primary contributor to ED in men under 40. Limiting alcohol to moderate intake preserves both hormonal balance and sexual function.

Related Goals

Find a Provider

The compounds on this page require medical supervision and prescriptions. A qualified provider can evaluate whether these approaches are appropriate for you.

Explore Practical Guides →

Important Disclaimer

The information provided on this page is for educational and informational purposes only. It is not intended as, and should not be construed as, medical advice, diagnosis, or treatment. The compounds, dosages, and protocols discussed are summaries of published research and do not constitute prescriptions or treatment plans. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Stay evidence-informed

Get research updates on compounds related to this goal, delivered to your inbox.

By subscribing, you consent to receive email newsletters from Truth In Peptides. You can unsubscribe at any time using the link in any email. We never sell or share your email address. See our Privacy Policy.